Thrombotic thrombocytopenic purpura in a child with systemic lupus erythematosus

Journal of Pediatric Hematology/Oncology

Volumn 33, Issue 3, 2011, Pages 221-223

  Thampi, Sheila ^a   Salmi, Darren ^c   Imashuku, Shinsaku ^d   Ducore, Jonathan ^b   Satake, Noriko ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c STANFORD UNIVERSITY   (United States)

^d Takasago seibu Hospital   (Japan)

Author keywords

ADAMTS 13; systemic lupus erythematosus; thrombotic thrombocytopenic purpura

Indexed keywords

ANTINUCLEAR ANTIBODY; BILIRUBIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; DOUBLE STRANDED DNA ANTIBODY; FRESH FROZEN PLASMA; HAPTOGLOBIN; HEMOGLOBIN; LACTATE DEHYDROGENASE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHOSPHOLIPID ANTIBODY; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ABDOMINAL PAIN; AFRICAN AMERICAN; ANEMIA; ARTICLE; AUTOIMMUNE DISEASE; BLOOD CULTURE; BLOOD SMEAR; BRAIN HEMORRHAGE; BRAIN VASCULITIS; CASE REPORT; CERVICAL LYMPHADENOPATHY; CHILD; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; COOMBS TEST; DELIRIUM; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; ENZYME ACTIVITY; ENZYME ASSAY; FAMILY HISTORY; FATIGUE; FEMALE; FEVER; FLUID RESUSCITATION; GENERAL CONDITION IMPROVEMENT; HEMOLYSIS; HEPATOMEGALY; HUMAN; HYPERVOLEMIA; HYPOTENSION; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; LUNG EDEMA; MENTAL DETERIORATION; MICROBIAL GROWTH; PERICARDIAL EFFUSION; PHYSICAL EXAMINATION; PLASMAPHERESIS; PLEURA EFFUSION; PRIORITY JOURNAL; PROTEINURIA; RETICULOCYTE COUNT; SCHOOL CHILD; SEPTIC SHOCK; SPONTANEOUS ABORTION; STAPHYLOCOCCUS AUREUS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT DURATION; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADAM PROTEINS; CHILD; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PURPURA, THROMBOTIC THROMBOCYTOPENIC;

EID: 79954416420     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e318208425d     Document Type: Article

References (18)

1. Burns ER, Lou Y, Pathak A. Morphologic diagnosis of thrombotic thrombocytopenic purpura. Am J Hematol. 2004;75:18-21. (Pubitemid 38040163)
2. Brunner HI, Freedman M, Silverman ED. Close relationship between systemic lupus erythematosus and thrombotic thrombocytopenic purpura in childhood. Arthritis Rheum. 1999;42:2346-2355.
3. Lichtin, Alan E. Autoimmune Hemolytic Anemia. The Merck Manuals-the online medical library. 〈Available at: http://www.merck.com/mmhe/sec14/ ch172/ch172f.html〉. 2008.
4. Mannucci PM, Peyvandi F. TTP and ADAMTS13: when is testing appropriate? Hematology Am Soc Hematol Educ Program. 2007;1:121-126.
5. Amorosi EL, Ultmann JE. Thrombotic thrombocytopenic purpura: report of 16 cases and review of the literature. Medicine. 1966;45:139-159.
6. Rock GA, Shumak KH, Buskard NA, et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med. 1991;325:393-397.
7. Tsai H-M. Deficiency of ADAMTS-13 in thrombotic and thrombocytopenic purpura. J Thromb Haemost. 2003;1:2038-2040.
8. Bell WR, Braine HG, Ness PM, et al. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. N Engl J Med. 1991;325:398-403.
9. Tsai H-M. Thrombotic thrombocytopenic purpura: a thrombotic disorder caused by ADAMTS13 deficiency. Hematol Oncol Clin North Am. 2007;21:609-632. (Pubitemid 47102556)
10. Zheng XL. Effect of plasma exchange on plasmaADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura. Blood. 2004;103:4043-4049. (Pubitemid 38685342)
11. Bianchi V, Robles R, Alberio L, et al. Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura. Blood. 2002;100:710-713. (Pubitemid 34761143)
12. Sadler JE. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura. Blood. 2008;112:11-18.
13. Mannuci PM, Vanoli M, Forza I. Von Willibrand factor cleaving protease (ADAMTS-13) in 123 patients with connective tissue diseases (systemic lupus erythematosus and systemic sclerosis). Haematologica. 2003;88:914-918. (Pubitemid 37128091)
14. Berube C, Mitchell L, Silverman E, et al. The relationship of antiphospholipid antibodies to thromboembolic events in pediatric patients with systemic lupus erythematosus: a cross sectional study. Pediatr Res. 1998;44:351-356. (Pubitemid 28389990)
15. Espinosa G, Bucciarelli S, Cervera R, et al. Thrombotic microangiopathic haemolytic anaemia and antiphopholipid antibodies. Ann Rheum Dis. 2004;63:730-736. (Pubitemid 38658405)
16. Diez-Ewald M, Torres-Guerra E, Vizcaino G, et al. Platelet function in patients with lupus anticoagulant and thrombosis. Invest Clin. 1995;36:13-21.
17. Asherson RA, Pierangelli S, Cervera R. Microangiopathic antiphospholipid associated syndromes revisited; new concepts relating to antiphospholipid antibodies and syndromes. J Rheumatol. 2007;34:1793-1795. (Pubitemid 350067635)
18. Kwok SK, Ju JH, Cho CS, et al. Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: risk factors and clinical outcome: a single centre study. Lupus. 2009;18:16-21.